Thermo Fisher [TMO] vs Danaher [DHR] Detailed Stock Comparison
Thermo Fisher
NYSE
Loading...
Danaher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Thermo Fisher wins in 13 metrics, Danaher wins in 6 metrics, with 0 ties. Thermo Fisher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Thermo Fisher | Danaher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.25 | 44.88 | Thermo Fisher |
| Price-to-Book Ratio | 3.66 | 2.89 | Danaher |
| Debt-to-Equity Ratio | 69.62 | 35.45 | Danaher |
| PEG Ratio | 4.97 | -1.20 | Danaher |
| EV/EBITDA | 19.74 | 22.16 | Thermo Fisher |
| Profit Margin (TTM) | 15.24% | 14.21% | Thermo Fisher |
| Operating Margin (TTM) | 17.84% | 20.12% | Danaher |
| EBITDA Margin (TTM) | 17.84% | 20.12% | Danaher |
| Return on Equity | 13.42% | 6.68% | Thermo Fisher |
| Return on Assets (TTM) | 4.97% | 4.01% | Thermo Fisher |
| Free Cash Flow (TTM) | $7.27B | $5.30B | Thermo Fisher |
| Dividend Yield | 0.31% | N/A | N/A |
| 1-Year Return | -19.04% | -21.68% | Thermo Fisher |
| Price-to-Sales Ratio (TTM) | 4.27 | 6.29 | Thermo Fisher |
| Enterprise Value | $213.59B | $166.64B | Thermo Fisher |
| EV/Revenue Ratio | 4.94 | 6.94 | Thermo Fisher |
| Gross Profit Margin (TTM) | 40.61% | 59.35% | Danaher |
| Revenue per Share (TTM) | $114 | $33 | Thermo Fisher |
| Earnings per Share (Diluted) | $17.31 | $4.70 | Thermo Fisher |
| Beta (Stock Volatility) | 0.75 | 0.76 | Thermo Fisher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Thermo Fisher vs Danaher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Thermo Fisher | 0.82% | 6.14% | 16.99% | 20.76% | -6.52% | -6.42% |
| Danaher | 0.34% | 5.17% | 9.37% | 10.46% | 3.13% | -8.22% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Thermo Fisher | -19.04% | -16.91% | 14.10% | 282.16% | 1,006.36% | 1,621.87% |
| Danaher | -21.68% | -18.64% | 14.50% | 260.93% | 763.76% | 1,053.88% |
Performance & Financial Health Analysis: Thermo Fisher vs Danaher
| Metric | TMO | DHR |
|---|---|---|
| Market Information | ||
| Market Cap | $184.66B | $151.04B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,008,780 | 3,241,650 |
| 90 Day Avg. Volume | 2,910,363 | 4,189,007 |
| Last Close | $489.01 | $210.93 |
| 52 Week Range | $385.46 - $627.88 | $171.00 - $279.90 |
| % from 52W High | -22.12% | -24.64% |
| All-Time High | $672.34 (Dec 27, 2021) | $296.06 (Sep 06, 2021) |
| % from All-Time High | -27.27% | -28.75% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.03% |
| Quarterly Earnings Growth | 0.05% | -0.39% |
| Financial Health | ||
| Profit Margin (TTM) | 0.15% | 0.14% |
| Operating Margin (TTM) | 0.18% | 0.20% |
| Return on Equity (TTM) | 0.13% | 0.07% |
| Debt to Equity (MRQ) | 69.62 | 35.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $133.77 | $73.10 |
| Cash per Share (MRQ) | $16.92 | $4.13 |
| Operating Cash Flow (TTM) | $7.58B | $6.17B |
| Levered Free Cash Flow (TTM) | $5.18B | $3.88B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.31% | N/A |
| Last 12-Month Dividend | $1.21 | N/A |
Valuation & Enterprise Metrics Analysis: Thermo Fisher vs Danaher
| Metric | TMO | DHR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.25 | 44.88 |
| Forward P/E | 20.82 | 25.17 |
| PEG Ratio | 4.97 | -1.20 |
| Price to Sales (TTM) | 4.27 | 6.29 |
| Price to Book (MRQ) | 3.66 | 2.89 |
| Market Capitalization | ||
| Market Capitalization | $184.66B | $151.04B |
| Enterprise Value | $213.59B | $166.64B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.94 | 6.94 |
| Enterprise to EBITDA | 19.74 | 22.16 |
| Risk & Other Metrics | ||
| Beta | 0.75 | 0.76 |
| Book Value per Share (MRQ) | $133.77 | $73.10 |
Financial Statements Comparison: Thermo Fisher vs Danaher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TMO | DHR |
|---|---|---|
| Revenue/Sales | $10.36B | $5.74B |
| Cost of Goods Sold | $6.13B | $2.23B |
| Gross Profit | $4.24B | $3.51B |
| Research & Development | $342.00M | $379.00M |
| Operating Income (EBIT) | $1.82B | $1.27B |
| EBITDA | $2.73B | $1.87B |
| Pre-Tax Income | $1.62B | $1.13B |
| Income Tax | $95.00M | $175.00M |
| Net Income (Profit) | $1.51B | $954.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TMO | DHR |
|---|---|---|
| Cash & Equivalents | $4.13B | $1.99B |
| Total Current Assets | $23.38B | $9.53B |
| Total Current Liabilities | $13.17B | $6.65B |
| Long-Term Debt | $31.37B | $15.98B |
| Total Shareholders Equity | $49.49B | $50.86B |
| Retained Earnings | $54.45B | $44.91B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TMO | DHR |
|---|---|---|
| Operating Cash Flow | $2.15B | $1.47B |
| Capital Expenditures | $-350.00M | $-239.00M |
| Free Cash Flow | $361.00M | $1.05B |
| Debt Repayment | $-838.00M | N/A |
| Common Stock Repurchase | $-2.00B | $-1.08B |
Short Interest & Institutional Ownership Analysis
| Metric | TMO | DHR |
|---|---|---|
| Shares Short | 3.71M | 8.45M |
| Short Ratio | 1.14 | 1.93 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 2,008,780 | 3,241,650 |
| Average Daily Volume (90 Day) | 2,910,363 | 4,189,007 |
| Shares Outstanding | 380.77M | 719.10M |
| Float Shares | 376.76M | 637.22M |
| % Held by Insiders | 0.00% | 0.11% |
| % Held by Institutions | 0.92% | 0.83% |
Dividend Analysis & Yield Comparison: Thermo Fisher vs Danaher
| Metric | TMO | DHR |
|---|---|---|
| Last 12-Month Dividend | $1.21 | N/A |
| Last 12-Month Dividend Yield | 0.31% | N/A |
| 3-Year Avg Annual Dividend | $1.33 | N/A |
| 3-Year Avg Dividend Yield | 0.07% | N/A |
| 3-Year Total Dividends | $3.99 | N/A |
| Ex-Dividend Date | Mar 14, 2025 | N/A |